Members

NeuBase Therapeutics




Member Type: Emerging Biotech/Pharmaceutical Companies

NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines that can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease. NeuBase's targeted PATrOL™ therapies are centered around its proprietary drug scaffold to address genetic diseases at the DNA or RNA level by combining the highly targeted approach of traditional genetic therapies with the broad organ distribution capabilities of small molecules.

https://www.neubasetherapeutics.com

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today




Download a Member List